Similar articles

• Recombinant FVIIa (NovoSeven) continuous infusion and total hip replacement in patients with haemophilia and high titre of inhibitors to FVIII: experience of two cases.

  Tagariello G, De Biasi E, Gajo GB, Risato R, Radossi P, Davoli PG, Traldi A. Tagariello G, et al. Haemophilia. 2000 Sep;6(5):581-3. doi: 10.1046/j.1365-2516.2000.00400.x. Haemophilia. 2000. PMID: 11012706
• Efficacy of different doses of recombinant activated factor VII in the treatment of haemophilia children with inhibitor.

  Chuansumrit A, Sirachainan N, Pakakasama S, Suebsangad A, Chotsuppakarn S, Wongwerawattanakoon P. Chuansumrit A, et al. Haemophilia. 2008 Sep;14(5):1143-4. doi: 10.1111/j.1365-2516.2008.01787.x. Epub 2008 Jul 9. Haemophilia. 2008. PMID: 18624705 No abstract available.
• Recombinant factor VIIa and factor VIII treatment for acquired factor VIII deficiency: a case of repeated thrombotic endotracheal occlusion in a mechanically ventilated patient.

  Lauer S, Westphal M, Fischer LG, Meissner A, Van Aken H, Freise H. Lauer S, et al. Crit Care. 2011;15(2):407. doi: 10.1186/cc10041. Epub 2011 Mar 9. Crit Care. 2011. PMID: 21418550 Free PMC article. No abstract available.
• Acquired factor VIII hemophilia in a trauma patient: case report and literature review.

  Robinson BR, Mueller EW, Burns JB, Maccallum MJ, McCarthy AP, Porembka DT. Robinson BR, et al. J Trauma. 2010 Feb;68(2):E35-8. doi: 10.1097/TA.0b013e318156869b. J Trauma. 2010. PMID: 20154529 Review. No abstract available.
• Treatment of patients with factor VIII and factor IX inhibitors with special focus on the use of recombinant factor VIIa.

  Hedner U. Hedner U. Thromb Haemost. 1999 Aug;82(2):531-9. Thromb Haemost. 1999. PMID: 10605747 Review. No abstract available.